Search Within

Elizabeth Chamberlain

Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. GSK Faculty (5)
  3. Neuroblastoma Service (5)
  4. Pediatrics, Department of (5)
  5. Tow Center for Developmental Oncology (TCDO) (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Nai-Kong Cheung (5)
  2. Shakeel Modak (4)
  3. Brian Kushner (3)
  4. Kim Kramer (3)
  5. Glenn Heller (2)
  6. Irene Cheung (2)

More People

Years
  1. 2016 (1)
  2. 2015 (1)
  3. 2014 (1)
  4. 2012 (2)
  5. 2003 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. International Journal of Cancer (1)
  3. Journal of Clinical Investigation (1)
  4. Pediatric Blood and Cancer (1)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. American Society for Clinical Investigation (1)
  4. John Wiley & Sons (1)
  5. Wiley Periodicals, Inc (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KIR3DL1 allelic polymorphism and HLA-B epitopes modulate response to anti-GD2 monoclonal antibody in patients with neuroblastoma
    Journal Article

    Forlenza, C. J.; Boudreau, J. E.; Zheng, J.; Le Luduec, J. B.; Chamberlain, E.; Heller, G.; Cheung, N. K. V.; Hsu, K. C.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Relapse in patients with high-risk neuroblastoma after treatment with 3F8+GM-CSF+CIS-retinoic acid in first complete/very good partial remission: Patterns, management and long-term outcome
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Chamberlain, E.; Wolden, S.; Laquaglia, M.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save
  • Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kramer, K.; Modak, S.; Kuk, D.; Pandit-Taskar, N.; Chamberlain, E.; Ostrovnaya, I.; Kushner, B. H.
    International Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • The inhibitory effect of GD3 on lymphocyte activation is independent on NKT cell recognition of ganglioside on CD1+ antigen presenting cells
    Meeting Abstract

    Wu, D. Y.; Chamberlain, E. G.; Grinman, L.; Chapman, P. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save